Both in Pharmaceuticals
Summit Therapeutics vs Madrigal Pharmaceuticals
Over the past year SMMT returned −13.3% and MDGL returned −3.9%; their daily moves had a correlation of 0.20.
SMMT −13.3% MDGL −3.9%Growth of $1, one year, split-adjusted
| Metric | SMMT | MDGL |
|---|---|---|
| Price | $15.80 | $396.32 |
| Market cap | $12.60B | $9.16B |
| Today | +6.76% | −8.08% |
| 1 month | −8.5% | −19.7% |
| 6 months | −9.9% | −21.1% |
| Year to date | −9.7% | −31.9% |
| 1 year | −16.4% | −5.4% |
| Revenue growth (YoY) | — | +71.2% |
| Gross margin | — | 100.0% |
| Net margin | — | −15.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 7.1× |
| Net cash | $690.7M | $498.0M |
| Dividend yield | — | — |
| Volatility (60d) | 70.7% | 35.1% |
| Short % of float | 29.5% | 14.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).